chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a healthcare professional on 29 SEPTEMER 2014. A 31-year-old female patient, whose concomitant medication were not reported, had received a dose of FLUZONE TIV, (batch number: UI189AC, expiry date: not reported) (dose in series, route of vaccination not reported) in left deltoid on 03-SEP-2014. On 03-SEP-2014, patient's arm became puffy, red and warm to touch/diagnosed it as a localized reaction. Corrective treatment was not reported and laboratory investigations were reported as none. Medical history was reported as Hypothyroidism, hypertension and Percutaneous Nephrolithotomy. Illness at the time of vaccination was reported as none. At the time of this report, the outcome of the event was reported as recovered. Documents held by sender: none. Follow up information was received on 02 JANUARY 2015: It was reported that the patient had a 7x8 cm erythematous and warm to touch on left deltoid. The patient had received corrective treatment of cool compress and BENADRYL. Follow up information was received on 04 MAY 2015: No new information reported:, however corrected event coding and labeling of events from previous version.
Swelling, redness, and pain of right upper arm about 9:00pm 02/26/21 for about 2 days Headache and fatigue about 8:00am 02/27/21 until next evening Dizziness, light-headedness and feeling hot without fever about 10:00am 02/27/21 until that evening Sensation of increased heaviness in knees about 4:00pm 02/27/21 noticed to be resolved upon rising from bed
red hot itchy painful lump;5cm x 3cm started 2 days p/vax;felt achy, fatigue;
NEXT EVENING LOWER GASTRIC DISTRESS BEGAN, DIARRHEA, CRAMPING, ETC..  DISCOMFORTS LASTED ABOUT3-4 DAYS
Received injection on Friday morning (2/5/10) on Saturday (2/6/10) arm, red, swollen and tender; Sunday (2/7/10) states fever 101 degrees, arm painful red, warm to touch, developed headache sx remain on clinic visit 2/9/10.
Feverish feeling, chills, malaise, headache, dizziness, body aches
Started as a small red warm, raised bump at injection site(golf ball sized). After 24 hours grown to larger red bump, warm and sore to the touch.
his neighbor was tired after the second shot; This is a spontaneous report from a contactable nurse reported for a patient (neighbor). This is report 2 of 2. This report is in regards to the caller's neighbor. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunization. It was reported that, the caller was a registered nurse called on behalf of himself in regards to the COVID vaccine. While reporting on himself, caller stated that, he had a neighbor that had the vaccine and he was tired from it. When caller was asked, whether he would provide information about his neighbor, he said his neighbor would not like it and he would prefer not to do report. The caller stated that, his neighbor was tired after the second shot. He was better after a couple of days. Stated that, he was fine after that. He got better right away. Stated that, he had no fever, chills, headache or nothing. He was just tired. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Fainted within 2-3 minutes after receiving the vaccine, fell forward and hit her head on the floor.  Regained consciousness immediately, developed a lump on her forehead, mark on her nose and left cheek where she hit the floor.  Had her lay down for 15 minutes, gave juice, water, and ice packs for her face.  She was a little sweaty but that went away quickly.  She then sat for another 15 minute before she got up to leave.
c/o h/a, fever, no thermometer, given APAP 10AUG97;appetite poor, sore throat cont febrile;11AUG97 loose stool x1, sore throat subside, appetite remains poor;remains febrile 102.7 -102.9 APAP q 4hr;gums red;dx hand,foot & mouth disease;
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 13-JUL-2016, the patient was vaccinated with improperly stored PROQUAD (lot # M010478, expiration date 01-SEP-2017, albumin status therapy type, dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
That one hurt; Adverse event; This case was reported by a consumer and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On 20th October 2017, the patient received the 1st dose of Shingles vaccine. On 21st October 2017, 1 days after receiving Shingles vaccine, the patient experienced injection site pain and adverse event. On an unknown date, the outcome of the injection site pain and adverse event were recovered/resolved.   The reporter considered the injection site pain and adverse event to be possibly related to Shingles vaccine.  Additional details were reported as follows: The age at the vaccination was not reported. The patient mentioned that once she had shingles and had to wait a couple of months before getting the vaccine. The patient told everyone else to get it but now it had been a year. The patient received vaccine in the other arm and she felt like ow, and that one hurt and hit her with a few side effects the next day but said that she had done her part.
Felt dizzy immediately after receiving Hi-dose flu. Vital signs stable. Symptoms improved shortly after.
p/vax pt c/o generalized aches & pain; feels feverish; pain in vax site; has superficial scab to inj site; pt states doesn't know if inj caused aches, pain & fever or another factor. advised tylenol or motrin
Patient didn't have an adverse effect she was given an expired dose, waiting on Moderna Manufacturer to call us back on what to do. Patient is pregnant unsure of due date she is around 20 weeks pregnant.
Eyes got "really really red"; kept seeing these little black spots; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Eyes got "really really red") and VISUAL IMPAIRMENT (kept seeing these little black spots) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR HYPERAEMIA (Eyes got "really really red") and VISUAL IMPAIRMENT (kept seeing these little black spots). At the time of the report, OCULAR HYPERAEMIA (Eyes got "really really red") and VISUAL IMPAIRMENT (kept seeing these little black spots) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's lab data included colonoscopy. The patient received steroid treatment in the eye. No concomitant medications were reported.
Pt received the vaccine on 4/16/21. Immediately upon administration, the patient felt moderate pain when the needle entered his skin. He said it just didn't feel right. When he got his first vaccine, he didn't even notice it. He noted that this second vaccine was given much further down than his first vaccine was given.  He noted that it was given approximately 7-8 cm below the acromion process. His arm was sore that day but it improved after 1 day. Then 7 days later, he had severe pain to his shoulder and upper arm. He woke up and he could not move his arm. He got up and had his son massage it and then after some time, it loosened up and he could move it.  He still has limited range of motion of his arm due to pain, his strength is decreased, the pain radiates down his arm, and the pain is impacting his work and daily activities. The pain is worse with rest.  He describes it as throbbing.
Temperature excursion information needed for a maximum temperature of 49 degree F for a duration of 10 hours out of range reason for the excursion was a problem with the refrigerator door with no reported adverse event; Initial information received on 22-Jun-2021 regarding an unsolicited valid  non-serious case received from from a pharmacist.  This case involves a patient of an unknown demographics whose temperature excursion information needed for a maximum temperature of 49 degree, F for a duration of 10 hours out of range and reason for the excursion was a problem with the refrigerator door with no reported adverse event while receiving vaccines meningococcal a-c-y-w135 (D conj) vaccine [Menactra] and diphtheria-2/tetanus/5 ac pertussis vaccine [Adacel] and while treated with dupilumab [Dupixent] via device not known, insulin lispro [Admelog] via device not known, insulin glargine [Lantus] via device not known and insulin glargine [Toujeo] via device not known.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient started taking meningococcal a-c-y-w135 vaccine, diphtheria-2/tetanus/5 ac pertussis vaccine ,dupilumab via device not known, insulin lispro via device not known, insulin glargine via device not known and insulin glargine via device not known. All with an unknowj other dosing details for an unknown indication.   Reportedly, temperature excursion information needed for a maximum temperature of 49-degree F for a duration of 10 hours out of range for the following suspect products. The reason for the excursion was a problem with the refrigerator door (Product temperature excursion issue, onset, and latency: unknown). The pharmacy's refrigerator door got stuck and did not seal itself. The pharmacist stated, the door got stuck on something and not sealed all the way.  No laboratory tests data were provided  Action taken :Not applicable  Outcome :Not applicable
I did have a low grade fever this morning of 101; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number and expiry date were not provided), via an unspecified route of administration on 21Jan2021 16:00 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  When probed for the concern, consumer stated, patient had a vaccine yesterday (21Jan2021) afternoon about 4 o'clock, patient had got the sheet about the side effects and some of those you know patient was not concerned about but patient did have a low grade fever this morning of 101 on 22Jan2021, patient's HR person has asked if patient would call to find out if that should be something that we should be alarmed of, if patient should not be at work or is that just a side effect from that, from the vaccine that should not be a concern.".  The outcome of the event was unknown.  Information about Lot/Batch has been requested.
Patient's wife called our call center to report that the patient experienced bruising and welps at injection site after administration.  She also reports that the patient had a stroke on 4/14/21.  This patient doesn't receive routine care at our facilities so we don't have any more information on the stroke and care of that situation.  Have tried to contact wife for more information with no luck.  Will continue to reach out.
Vaginal yeast infection; This case was reported by a consumer and described the occurrence of vaginal yeast infection in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced vaginal yeast infection. On an unknown date, the outcome of the vaginal yeast infection was unknown.   It was unknown if the reporter considered the vaginal yeast infection to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had vaginal yeast infection for few days
Immediate pain upon injection down arm into fingers.  Pain continues months later with weakness in arm and shoulder.  Pain prevents patient from some activities of daily living.  Arm and shoulder pain while sleeping and during arm and hand use.  Pain has not resolved or lessened over time.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. Patient's medical history and concurrent conditions was not reported. On 19-FEB-2015 the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) 0.5 ml, subcutaneously (lot # K008579, expiry date: 13-DEC-2015). No adverse effects reported. No product quality complaint (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
11/11/14 Patient has had flu shots on other occasions, always get faint. Administered flu shot and patient became flush, but said okay and then he fainted, head forward on table. Immediately asked someone to call 911. We moved him up chair to try to lay him flat on the floor. He came to and I monitored his vitals; pulse. Tried to use blood pressure cuff, but would not work error #1, error #2. Patient finally patient felt better and I advised any unusual or anaphylactic symptoms to call 911 immediately, or go to see MD to verify okay. Security officers came down to take story. 911 never arrived, apparently was canceled, not sure why.
15-year-old female with history of C3 glomerulonephritis since 2019 received Pfizer Covid vaccination #3 (immunosuppressed patient) in August 2021 associated with fever, hypertension, fatigue. Her C3 GN was well controlled prior to Covid vaccination, on mycophenolate. Subsequently she developed high-grade proteinuria leading to kidney biopsy in December 2021 which demonstrated concern of IgA nephropathy on background of C3 glomerulonephritis. The new IgA nephropathy findings were felt to most likely relate to immune stimulus following Covid vaccination.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. About 20 years previously, she had allergic reaction of hives and trouble breathing when she received iodine dye for an unspecified test. The patient had no other pertinent medical history. On 24-JUN-2013 the patient was vaccinated with ZOSTAVAX. Lot# was not provided. Concomitant vaccine included PNEUMOVAX23 administered on 24-JUN-2013. Concomitant medications included thyroid and blood pressure medications. On 26-JUN-2013, two days later, the patient had a sore, itchy red welt on the arm she received ZOSTAVAX. When seen on 29-JUN-2013, the patient showed improvement at the ZOSTAVAX injection site. The ZOSTAVAX injection site had no welt and just little bit of redness. No treatment was given. No lab test was done. The patient did not seek medical attention. Additional information has been requested.
I had chest pain in the center. It still going but not as bad. I had running nose, cough, fever, and chills. These lasted for about a week. On Dec. 24th, I was tested positive for Covid-19. I went to my doctor about it. I tested positive there also at the doctor offices.
Rash; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; lamotrigine (LAMOTRIGINE), (Batch/Lot number: unknown) at 125 mg for migraine. The patient's relevant medical history included: "terrible migraine " (ongoing), notes: Intent: Medical History. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number unknown, Manufacturer unknown), for COVID-19 Immunisation.  The following information was reported: RASH (non-serious), outcome "unknown". The action taken for lamotrigine was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. The patient experienced no adverse event. Additional information is not expected.
My injection site is red/red spot; This case was reported by a consumer and described the occurrence of injection site erythema in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th January 2020, the patient received Shingrix. On 26th January 2020, 2 days after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was recovering/resolving.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  The patient experienced injection site was red about the size of a large Booca ball after receiving Shingrix. The red spot on arm which was basketball sized on 26th January 2020, which was fading away looks much better and seems like it will be ok. The patients pharmacist advised put ice on the spot. No other information was provided.
Experienced muscle/joint stiffness for an entire week; Experienced muscle/joint stiffness for an entire week; Extremely fatigued; Felt unwell; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 10:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), tocopherol (VIT. E), vitamin d nos (VIT D), glucosamine (MANUFACTURER UNKNOWN) and calcium carbonate (CALCIUM), all from unknown date for an unknown indication. The patient previously took Codeine (MANUFACTURER UNKNOWN) and experienced allergy. The patient previously received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Mar2021 at 11:45 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 11:00, the patient felt unwell, extremely fatigued and experienced muscle/joint stiffness for an entire week. The patient did not receive any treatment for the event. The patient was somewhat better at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events unwell, extremely fatigued and muscle/joint stiffness was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt recvd vax on 5JUL92 devel a pos blood culture for haemophilus influenza, type a; pt was hospitalized; addtl info has been requested;
Pt recvd vax on 29SEP92 & 30 minutes following vax devel SOB, palpitations & a rash; pt wa seen in ER & treated w/Epi & DPH & released to home; No further details were provided;
Autism A 60-day follow up report received 6/23/2003 adds: Autism. Speech disability. Digestive problems. Dilated pupils. Light, sound, taste sensitivity. Social problems relatedness. Sleep disorder. Inability to properly metabolize foods. I've asked this before. What is the CDC-VAERS doing about this. Still, no recall of thimerasol-containing vaccines, so children will continue to get poisoned, and some vaccines are still manufactured with it. The drug companies come out smelling like a rose while thousands of children and their families got screwed! Stop monitoring and do something. Please, have them stop sending thimerasol-containing vaccines to third world countries now. Order vials still on the shelves in the US recalled now!
Initially sore at injection site, slight redness,  Ten days late red area is larger (about 3 inches across), slightly itchy, slighly sore and warmer to the touch than surrounding area.
The next day I woke up feeling yucky. The second day, I was worse. I developed a sinus infection and bronchitis. I wasn't able to get an appointment until the 4th day. I was given antibiotics by my primary care doctor. On day 5, I went to urgent care and was given another round of antibiotics. A week later, I went to the ER and received a steroid and another round of antibiotics. After about 3 days, it started to clear up. I was still weak, but was able to go back to work.
Body aches starting 1 day after and continuing into the 2nd day after the vaccination and treated with tylenol and Ibuprofen.; Fever starting 1 day after and continuing into the 2nd day after the vaccination and treated with tylenol and Ibuprofen.; Chills starting 1 day after and continuing into the 2nd day after the vaccination and treated with tylenol and Ibuprofen.; This is a spontaneous report from a non-contactable consumer. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via intramuscular route of administration in the right arm on 12Jun2021 as a single dose for COVID-19 immunisation. Medical history was unknown. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via intramuscular route of administration in the right arm on 17May2021 as a single dose for COVID-19 immunisation. On 13Jun2021, the patient experienced body aches, fever and chills starting one day after and continuing into the second day after the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events, body aches, fever and chills which included treatment with Tylenol and ibuprofen. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events body aches, fever and chills was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Tenderness of lt leg evening of 10JUN93 mod swelling from hip & knee on morning of 11JUN93 unable to walk on leg; has been on APAP;
One wk after shot my upper arm swelled about 4 in yon diameter and was hard and very itchy. It went away after 2 days